About US
Contact us
-
Deals this week: Cell Medica Limited, Cloaked Therapeutics, SynCore BiotechCell Medica Limitedand University College London (UCL) have entered a research collaboration agreement to develop leading-edge modified T-cell receptor (TCR) products for the treatment of cancer. Acc2016/8/30
-
Eisai’s anticancer agent approved for additional indication of CLL in JapanEisai’s anticancer agent treakisym for injection 100mg has received approval for an additional indication of chronic lymphocytic leukaemia (CLL) in Japan. CLL is a blood cancer that is characterised2016/8/29
-
Johns Hopkins Medicine opens new Zika virus treatment and research centreJohns Hopkins Medicine has opened a new centre to provide comprehensive care to patients infected with theZika virus. The Wilmer Eye Institute, which treats eye concerns associated with Zika virus, l2016/8/29
-
Join AtoZ-Cro at Marcus Evans Event in GermanyAtoZ-CRO will be attending Marcus Evans event in Cologne, Germany. The 14th annual Evolution Summit is the premium forum bringing elite buyers and sellers together. As an invitation-only event taking2016/8/26
-
Report: Unmet need for safer anti-arrhythmic drugs in atrial fibrillation market to continue through to 2025Unavailability of safer anti-arrhythmic drugs is expected to be major issue in the atrial fibrillation market, according to a new report from GlobalData. Titled 'PharmaPoint: Atrial Fibrillation – Gl2016/8/26
-
BARDA contracts SAB Biotherapeutics to advance MERS treatmentThe US Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA) has awardeda $5.3m contract to US-based SAB Biotherapeuticsfor theadvancement offir2016/8/25
-
EMA accepts Mylan’s MAA for proposed biosimilar trastuzumab for reviewThe European Medicines Agency (EMA) has accepted for review Mylan's marketing authorisation application (MAA) for a proposed biosimilar Trastuzumab, MYL-1401O, to treat certain human epidermal growth2016/8/25
-
Study shows new drug combination slows lung cancer cell growthScientists at the Institute of Cancer Research, London, and the Institut Gustave Roussy in France have shown that a new drug combination slows cancer cell growth in a type of non-small-cell lung cance2016/8/24
-
Pfizer to acquire AstraZeneca's anti-infectives business for $1.5bnPfizer has agreed to acquire small molecule anti-infectives business from AstraZeneca in a deal valued at approximately $1.5bn. With this deal, Pfizer will gain commercialisation and development righ2016/8/24
-
India develops world’s first leprosy vaccineIndia has developed the world’s first leprosy vaccine, which is soon to be planned for trials within five districts of Bihar and Gujarat states. The latest move is part of the country's efforts to el2016/8/23